NIDA Clinical Trials Network: New York Node - GY22 Integrating MOUD in Non-Medical Settings to Improve Treatment and Retention of Black/AA Persons
NIDA 临床试验网络:纽约节点 - GY22 在非医疗环境中整合 MOUD,以改善黑人/AA 人的治疗和保留
基本信息
- 批准号:10809985
- 负责人:
- 金额:$ 6.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAccelerationAccident and Emergency departmentAddressAdoptionAdvocacyAfrican American populationAlaska NativeAlcoholsAmerican IndiansAncillary StudyAreaBehavior TherapyBehavioralBlack PopulationsBlack raceBuprenorphineCOVID-19CaringChicagoChurchCitiesClinicClinicalClinical ManagementClinical TrialsClinical Trials NetworkCollaborationsCommunitiesCommunity Health AidesConsolidated Framework for Implementation ResearchCounselingCountyCriminal JusticeData AnalyticsData ScienceEffectivenessElectronic Health RecordEvidence based interventionFaithFederally Qualified Health CenterFrightFundingFutureGenerationsHealthHealth PersonnelHealthcare SystemsHuman ResourcesIndividualInfrastructureInjectionsInterventionLeadLegalLong IslandMainstreamingMeasuresMedicaid eligibilityMedicalMental disordersMinorityModelingNaltrexoneNational Institute of Drug AbuseNew YorkNicotineOpioidParticipantPatientsPersonsPharmaceutical PreparationsPharmacotherapyPoliciesPolicy MakerPreventionPrevention trialPrimary CareProviderPublic HealthRandomizedRecoveryResearchResearch PersonnelScheduleScienceScientistServicesSiteSocioeconomic FactorsSpecialistSubstance Use DisorderSurveysSystemTechnologyTelemedicineTrainingTranslatingTreatment outcomeTrustVisionVisitWashingtonWithdrawalWomanWorkaddictioncollaborative carecommunity engagementcommunity organizationscommunity settingcomparative effectivenessdigitaleffectiveness evaluationeffectiveness/implementation trialexperiencehealth care settingshealth economicsimplementation barriersimplementation facilitationimplementation facilitatorsimplementation scienceimprovedinnovationmedical specialtiesmedication compliancemetropolitannovelopioid epidemicopioid mortalityopioid overdoseopioid useopioid use disorderoutreachoverdose deathpatient retentionpeer recoverypre-exposure prophylaxispredictive modelingprimary care providerprior authorizationpsychoeducationpsychoeducationalracial disparitysocial stigmastimulant dependencetreatment programvirtual
项目摘要
The New York Node (NYN) of the NIDA CTN, led by John Rotrosen and Edward Nunes, represents the 2010
merger of the New York and Long Island Nodes, which had been part of the CTN since 2000 and 2001,
respectively. This fourth competing renewal application builds on both a strong and successful infrastructure to
manage clinical trials, and a track record of innovation and successful implementation of trials in mainstream
healthcare settings where most SUD patients are seen. We contribute expertise in virtually all key CTN
priorities outlined in RFA-DA-20-024, including: integration of SUD treatment and prevention in mainstream
settings (primary care, emergency departments, criminal justice); leveraging the electronic health record to
support improved and expanded care; developing medications and behavioral therapies; co-occurring medical
and psychiatric disorders; women and minorities; digital and other technology-based interventions; data
science including novel data analytic approaches; and implementation science, health economics, advocacy,
and policy to sustain evidence-based interventions. In the new funding period, the NYN will lead or co-lead
seven ambitious projects, all scheduled to begin in 2019 or 2020: CTN-0079-A1 Ancillary Study of the Adoption
and Sustainability of ED-Initiated Buprenorphine; CTN-0082 Implementation Survey of PrEP and Opioid Use
Related Services in STI Clinics and Community Based Organizations; CTN-0094 Individual Level Predictive
Modeling of Opioid Use Disorder Treatment Outcome; CTN-0096 Culturally Centered MAT for OUD
Implementation Facilitation for Primary Care and Addiction Treatment Programs Serving American
Indian/Alaska Natives; CTN-0097 Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT):
Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder; CTN-0100 Optimizing
Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy; and CTN-0101
Subthreshold Opioid Use Disorder Prevention (STOP) Trial. We will also continue to help develop new trials in
CTN, including in the area of stimulant dependence, and to supply sites for CTN trials.
To support this, we have built a network of collaborating researchers, providers, and policy makers from
academia, community-based addiction treatment programs, large multifaceted healthcare systems, and NY
City and State agencies, all in the nation’s largest and most diverse metropolitan area. We have established a
track record of substantial contributions to the CTN, building on our work through deliberate, rigorous, and
stepwise improvements. Our vision for the Network’s future includes work built around addressing gaps
highlighted by the opioid treatment cascade, interventions for stimulant dependence, effective use of the CTN
platform to enable a broad range of non-CTN studies, and a continued commitment to training a new
generation of addictions clinical researchers. Further, we partner with implementation scientists, health
economists, advocacy groups, and policy experts to maximize the sustainability of effective new interventions.
由John Rotrosen和Edward Nunes领导的NIDA CTN的纽约节点(NYN)代表着2010年
合并纽约和长岛节点,这两个节点自2000年和2001年以来一直是CTN的一部分,
分别进行了分析。这第四个竞争对手的续订应用程序建立在强大且成功的基础架构之上,以
管理临床试验,以及主流试验的创新和成功实施的跟踪记录
大多数SUD患者都能看到的医疗保健环境。我们提供几乎所有关键CTN的专业知识
RFA-DA-20-024中概述的优先事项,包括:将SUD治疗和预防纳入主流
环境(初级保健、急诊科、刑事司法);利用电子健康记录
支持改善和扩大护理;开发药物和行为疗法;共同发生的医疗
和精神障碍;妇女和少数群体;数字和其他以技术为基础的干预;数据
科学,包括新的数据分析方法;以及实施科学、卫生经济学、宣传、
以及维持循证干预的政策。在新的资助期内,纽约银行将牵头或联合牵头
7个雄心勃勃的项目,全部计划于2019年或2020年开始:CTN-0079-A1采纳附属研究
ED引发的丁丙诺啡的安全性和可持续性;关于PrEP和阿片类药物使用的CTN-0082实施调查
性传播感染诊所和社区组织的相关服务;CTN-0094个人水平预测
阿片类药物使用障碍治疗结果的模型化;CTN-0096以文化为中心的OUD垫
促进为美国人服务的初级保健和成瘾治疗方案的实施
印度/阿拉斯加原住民;CTN-0097克服戒断症状,开始纳曲酮快速治疗(SWIFT):
提高注射用纳曲酮治疗阿片类药物使用障碍的实际疗效CTN-0100优化
阿片使用障碍药物治疗的保留、持续时间和停用策略;和CTN-0101
阈值下阿片类药物使用障碍预防(STOP)试验。我们还将继续帮助开发新的试验
CTN,包括在兴奋剂依赖领域,并为CTN试验提供场地。
为了支持这一点,我们从以下方面建立了一个由研究人员、提供商和政策制定者组成的协作网络
学术界、以社区为基础的成瘾治疗计划、大型多方面的医疗保健系统,以及纽约
城市和州机构,都在全国最大和最多样化的大都市地区。我们已经建立了一个
在我们工作的基础上,通过深思熟虑、严格和
循序渐进的改进。我们对网络未来的愿景包括围绕解决差距而构建的工作
突出的是阿片类药物治疗级联、对兴奋剂依赖的干预、CTN的有效使用
支持广泛的非CTN研究的平台,并继续致力于培训新的
一代成瘾的临床研究人员。此外,我们与实施科学家、卫生部门
经济学家、倡导团体和政策专家,以最大限度地提高有效新干预措施的可持续性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer McNeely其他文献
Jennifer McNeely的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer McNeely', 18)}}的其他基金
Leveraging technology to address unhealthy drug use in primary care settings
利用技术解决初级保健机构中不健康的药物使用问题
- 批准号:
9016861 - 财政年份:2016
- 资助金额:
$ 6.13万 - 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
- 批准号:
8667798 - 财政年份:2013
- 资助金额:
$ 6.13万 - 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
- 批准号:
8028169 - 财政年份:2010
- 资助金额:
$ 6.13万 - 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
- 批准号:
8323430 - 财政年份:2010
- 资助金额:
$ 6.13万 - 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
- 批准号:
8144836 - 财政年份:2010
- 资助金额:
$ 6.13万 - 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
- 批准号:
8521227 - 财政年份:2010
- 资助金额:
$ 6.13万 - 项目类别:
Screening for Substance Use with Computer Assisted Self Interview in Primary Care
在初级保健中通过计算机辅助自我访谈筛查药物使用
- 批准号:
8721383 - 财政年份:2010
- 资助金额:
$ 6.13万 - 项目类别:
相似海外基金
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 6.13万 - 项目类别:
Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 6.13万 - 项目类别:
Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 6.13万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 6.13万 - 项目类别:
Continuing Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 6.13万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 6.13万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 6.13万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 6.13万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 6.13万 - 项目类别:
Continuing Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
- 批准号:
23H01186 - 财政年份:2023
- 资助金额:
$ 6.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)